Browse > Article
http://dx.doi.org/10.3345/kjp.2009.52.3.340

Development of metabolic syndrome and its correlation with insulin resistance in adult patients with Turner syndrome  

Kim, Joo Hwa (Department of Pediatrics, College of Medicine, Seoul National University)
Kang, Min Jae (Department of Pediatrics, College of Medicine, Seoul National University)
Shin, Choong Ho (Department of Pediatrics, College of Medicine, Seoul National University)
Yang, Sei Won (Department of Pediatrics, College of Medicine, Seoul National University)
Publication Information
Clinical and Experimental Pediatrics / v.52, no.3, 2009 , pp. 370-375 More about this Journal
Abstract
Purpose : The risk of metabolic syndrome (MS) and cardiovascular disease in Turner syndrome (TS) patients is high. We analyzed metabolic factors in adults with TS and evaluated the metabolic risk of insulin resistance. Methods : Forty-three adults with TS were enrolled. The frequency of MS and the values of the metabolic factors were analyzed. Patients were divided into insulin resistant and non-resistant groups according to values of homeostasis model assessment of insulin resistance (HOMA-IR). The correlations of HOMA-IR with metabolic parameters were analyzed. Results : The frequency of MS was 7% and those of each metabolic parameter were as follows: insulin resistance, 16.3%; central obesity, 15.4%; hypertriglyceridemia, 2.3%; low HDL cholesterol, 9.3%; hypertension, 36.8%. The insulin-resistant group had significantly higher values of body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), HOMA-IR, and systolic blood pressure (SBP) than the non-resistant group (P<0.05). HOMA-IR showed a significantly positive correlation with BMI, WC, FPG, and SBP and showed a negative correlation with HDL cholesterol. Conclusion : This study suggests that adults with TS have a high risk of metabolic syndrome, and insulin resistance is correlated with metabolic factors. Therefore, TS patients should have their metabolic parameters monitored regularly to minimize metabolic complications and prevent cardiovascular diseases.
Keywords
Turner syndrome; Adult; Metabolic syndrome; Cardiovascular disease; Insulin resistance;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151:657-87   DOI   ScienceOn
2 Cicognani A, Mazzanti L, Tassinari D, Pellacani A, Forabosco A, Landi L, et al. Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr 1988;148:64-8   DOI   ScienceOn
3 Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9   DOI   ScienceOn
4 Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998;21:1062-70   DOI   ScienceOn
5 Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-58   DOI   ScienceOn
6 Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65:177-88   DOI   ScienceOn
7 Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 2003; 290:2127-8   DOI   ScienceOn
8 Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004;351:1227-38   DOI   PUBMED   ScienceOn
9 Lee S, Choi S, Kim HJ, Chung, YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006;21:695-700   DOI   ScienceOn
10 Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001;109(2 Suppl):135S-48S   DOI   ScienceOn
11 Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEP- ATPIII among the urban Korean population. Korean J Med 2002;63:290-9
12 Bondy CA. Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10-25
13 Aligeti VR, Horn HR. Turner's syndrome and coronary artery disease. Am J Cardiol 2007;99:741-2   DOI   ScienceOn
14 Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, et al. Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 1991; 72:832-6   DOI
15 Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf) 1998;49:447-50   DOI   ScienceOn
16 Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000; 52:363-70   DOI   ScienceOn
17 Facchini FS, Hua N, Abbasi F, Raven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8   DOI   ScienceOn
18 Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16   DOI   ScienceOn
19 Finegood DT, Hramiak IM, DupreJ. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990;70:1538-49   DOI
20 Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-9   DOI   ScienceOn
21 Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63   DOI   ScienceOn
22 Virdis R, Cantu MC, Ghizzoni L, Ammenti A, Nori G, Volta C, et al. Blood pressure behaviour and control in Turner syndrome. Clin Exp Hypertens A 1986;8:787-91   DOI
23 Yip J, Facchini FS, Reaven GM. Resistance to insulin- mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-6   DOI   ScienceOn
24 Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB, Jr. Lipid abnormalities in Turner syndrome. J Pediatr 1995;126:242-5   DOI   ScienceOn
25 Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607   DOI   PUBMED   ScienceOn
26 Expert Panel on Detection, Evaluation Treatment of High Blood Cholesterol in, Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97   DOI   PUBMED   ScienceOn
27 Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5   DOI   ScienceOn
28 Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991;87:81-3   DOI   PUBMED
29 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9   DOI   ScienceOn
30 Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, et al. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 2004;89:3516- 20   DOI   ScienceOn